• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核病自然史:HIV 阴性患者未经治疗的肺结核的持续时间和死亡率:系统评价。

Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.

机构信息

KNCV Tuberculosis Foundation, The Hague, The Netherlands.

出版信息

PLoS One. 2011 Apr 4;6(4):e17601. doi: 10.1371/journal.pone.0017601.

DOI:10.1371/journal.pone.0017601
PMID:21483732
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3070694/
Abstract

BACKGROUND

The prognosis, specifically the case fatality and duration, of untreated tuberculosis is important as many patients are not correctly diagnosed and therefore receive inadequate or no treatment. Furthermore, duration and case fatality of tuberculosis are key parameters in interpreting epidemiological data.

METHODOLOGY AND PRINCIPAL FINDINGS

To estimate the duration and case fatality of untreated pulmonary tuberculosis in HIV negative patients we reviewed studies from the pre-chemotherapy era. Untreated smear-positive tuberculosis among HIV negative individuals has a 10-year case fatality variously reported between 53% and 86%, with a weighted mean of 70%. Ten-year case fatality of culture-positive smear-negative tuberculosis was nowhere reported directly but can be indirectly estimated to be approximately 20%. The duration of tuberculosis from onset to cure or death is approximately 3 years and appears to be similar for smear-positive and smear-negative tuberculosis.

CONCLUSIONS

Current models of untreated tuberculosis that assume a total duration of 2 years until self-cure or death underestimate the duration of disease by about one year, but their case fatality estimates of 70% for smear-positive and 20% for culture-positive smear-negative tuberculosis appear to be satisfactory.

摘要

背景

未经治疗的肺结核的预后,特别是病死率和持续时间,非常重要,因为许多患者未得到正确诊断,因此未接受充分或未接受治疗。此外,肺结核的持续时间和病死率是解释流行病学数据的关键参数。

方法和主要发现

为了估计 HIV 阴性患者未经治疗的肺结核的持续时间和病死率,我们回顾了化疗前时代的研究。在 HIV 阴性个体中,未经治疗的涂片阳性肺结核的 10 年病死率有报道在 53%至 86%之间不等,加权平均值为 70%。未直接报告培养阳性涂片阴性肺结核的 10 年病死率,但可间接估计约为 20%。从发病到治愈或死亡的肺结核持续时间约为 3 年,并且似乎与涂片阳性和涂片阴性肺结核相似。

结论

目前假设未经治疗的肺结核总持续时间为 2 年,直至自行治愈或死亡的模型低估了疾病持续时间约 1 年,但它们对涂片阳性和培养阳性涂片阴性肺结核的病死率估计(分别为 70%和 20%)似乎令人满意。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/3070694/22ae457bb22f/pone.0017601.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/3070694/22ae457bb22f/pone.0017601.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a980/3070694/22ae457bb22f/pone.0017601.g001.jpg

相似文献

1
Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review.结核病自然史:HIV 阴性患者未经治疗的肺结核的持续时间和死亡率:系统评价。
PLoS One. 2011 Apr 4;6(4):e17601. doi: 10.1371/journal.pone.0017601.
2
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
3
Low-complexity manual nucleic acid amplification tests for pulmonary tuberculosis in children.用于儿童肺结核的低复杂度手动核酸扩增检测
Cochrane Database Syst Rev. 2025 Jun 25;6(6):CD015806. doi: 10.1002/14651858.CD015806.pub2.
4
Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review.用于诊断肺结核的商业血清学抗体检测试验:一项系统评价
PLoS Med. 2007 Jun;4(6):e202. doi: 10.1371/journal.pmed.0040202.
5
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children.Xpert MTB/RIF Ultra assay 用于儿童结核病和利福平耐药检测。
Cochrane Database Syst Rev. 2022 Sep 6;9(9):CD013359. doi: 10.1002/14651858.CD013359.pub3.
6
A systematic review of rapid diagnostic tests for the detection of tuberculosis infection.一项关于用于检测结核感染的快速诊断检测的系统评价。
Health Technol Assess. 2007 Jan;11(3):1-196. doi: 10.3310/hta11030.
7
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
8
Risk of thromboembolism in patients with COVID-19 who are using hormonal contraception.COVID-19 患者使用激素避孕的血栓栓塞风险。
Cochrane Database Syst Rev. 2023 Jan 9;1(1):CD014908. doi: 10.1002/14651858.CD014908.pub2.
9
A systematic review and economic evaluation of epoetin alpha, epoetin beta and darbepoetin alpha in anaemia associated with cancer, especially that attributable to cancer treatment.促红细胞生成素α、促红细胞生成素β和达比加群酯治疗癌症相关性贫血(尤其是癌症治疗所致贫血)的系统评价与经济学评估
Health Technol Assess. 2007 Apr;11(13):1-202, iii-iv. doi: 10.3310/hta11130.
10
Symptom- and chest-radiography screening for active pulmonary tuberculosis in HIV-negative adults and adults with unknown HIV status.症状和胸部 X 线筛查在 HIV 阴性的成年人和 HIV 状态未知的成年人中的活动性肺结核。
Cochrane Database Syst Rev. 2022 Mar 23;3(3):CD010890. doi: 10.1002/14651858.CD010890.pub2.

引用本文的文献

1
Burden of tuberculosis in Eastern Africa region from 1990-2021: A systematic analysis for the Global Burden of Disease 2021 Study.1990 - 2021年东非地区的结核病负担:全球疾病负担2021研究的系统分析
PLoS One. 2025 Sep 2;20(9):e0331035. doi: 10.1371/journal.pone.0331035. eCollection 2025.
2
Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014-2024) ClinSurv HIV cohort: A large case series.土耳其HIV感染者中结核病合并感染的流行病学和临床分析及转归(2014 - 2024年)ClinSurv HIV队列研究:一项大型病例系列研究
PLoS One. 2025 Aug 1;20(8):e0329267. doi: 10.1371/journal.pone.0329267. eCollection 2025.
3

本文引用的文献

1
On the Duration of Phthisis Pulmonalis and on certain conditions which influence it.论肺结核的病程及某些影响因素
Med Chir Trans. 1871;54:95-127. doi: 10.1177/095952877105400105.
2
Survival Rates in Pulmonary Tuberculosis.肺结核的存活率
Br Med J. 1943 Dec 4;2(4326):721. doi: 10.1136/bmj.2.4326.721.
3
Respiratory Tuberculosis: Interval between Notification and Death.呼吸道结核病:报告至死亡的间隔时间
Implications of progressive lung damage and post-tuberculosis sequelae for the health benefits of prompt tuberculosis treatment in high HIV prevalence settings: a mathematical modelling analysis.
在艾滋病毒高流行地区,进展性肺损伤和结核病后遗症对及时治疗结核病的健康益处的影响:一项数学建模分析
Lancet Glob Health. 2025 Jul;13(7):e1240-e1249. doi: 10.1016/S2214-109X(25)00114-7.
4
Exploring perspectives on the benefits of a tuberculosis short-treatment regimen: a cross-sectional study on treatment experiences and perceptions.探索对结核病短程治疗方案益处的看法:一项关于治疗经历和认知的横断面研究
J Bras Pneumol. 2025 Jun 13;51(2):e20250059. doi: 10.36416/1806-3756/e20250059.
5
Data-driven targets for reducing the global burden of TB.减少全球结核病负担的数据驱动型目标。
IJTLD Open. 2025 Jun 13;2(6):352-358. doi: 10.5588/ijtldopen.25.0014. eCollection 2025 Jun.
6
A review of the efficacy of clinical tuberculosis vaccine candidates in mouse models.临床结核病候选疫苗在小鼠模型中的疗效综述。
Front Immunol. 2025 May 29;16:1609136. doi: 10.3389/fimmu.2025.1609136. eCollection 2025.
7
Sex-related absolute inequalities in tuberculosis incidence in 47 countries in Africa.非洲47个国家结核病发病率的性别相关绝对不平等现象。
BMC Med. 2025 Jun 2;23(1):324. doi: 10.1186/s12916-025-04098-8.
8
Prevalence, Progression, and Treatment of Asymptomatic Tuberculosis: A Prospective Cohort Study in Lanxi County, Zhejiang Province, China.无症状结核病的患病率、进展及治疗:中国浙江省兰溪县的一项前瞻性队列研究
Open Forum Infect Dis. 2025 May 12;12(5):ofaf275. doi: 10.1093/ofid/ofaf275. eCollection 2025 May.
9
"A custome lothsome": Investigating the association between tobacco consumption and respiratory inflammation in two post-medieval English populations (c. CE 1500-1855).“一种令人厌恶的习俗”:探究后中世纪两个英国人群体(约公元1500年 - 1855年)中烟草消费与呼吸道炎症之间的关联
PLoS One. 2025 May 22;20(5):e0324045. doi: 10.1371/journal.pone.0324045. eCollection 2025.
10
Importance of confirmatory test characteristics in optimizing community-based screening for tuberculosis: An epidemiological modeling analysis.验证性检测特征在优化基于社区的结核病筛查中的重要性:一项流行病学建模分析
medRxiv. 2025 May 11:2025.05.09.25327330. doi: 10.1101/2025.05.09.25327330.
Br Med J. 1943 Nov 27;2(4325):684-5. doi: 10.1136/bmj.2.4325.684.
4
PROGNOSIS IN PULMONARY TUBERCULOSIS.肺结核的预后
Br Med J. 1933 Mar 25;1(3768):507-9. doi: 10.1136/bmj.1.3768.507.
5
PROGNOSIS IN PULMONARY TUBERCULOSIS.肺结核的预后
Br Med J. 1928 Mar 17;1(3506):436-7. doi: 10.1136/bmj.1.3506.436.
6
The Harveian Lectures on Prognosis and Treatment in Pulmonary Tuberculosis: Delivered before the Harveian Society of London, November, 1900.《关于肺结核预后与治疗的哈维讲座:1900年11月在伦敦哈维学会发表》
Br Med J. 1900 Dec 15;2(2085):1695-7. doi: 10.1136/bmj.2.2085.1695.
7
The Harveian Lectures on Prognosis and Treatment in Pulmonary Tuberculosis: Delivered before the Harveian Society of London, November, 1900.《关于肺结核预后与治疗的哈维讲座:1900年11月在伦敦哈维学会发表》
Br Med J. 1900 Dec 8;2(2084):1637-9. doi: 10.1136/bmj.2.2084.1637.
8
The Harveian Lectures on Prognosis and Treatment in Pulmonary Tuberculosis: Delivered before the Harveian Society of London, November, 1900.《关于肺结核预后与治疗的哈维安讲座:1900年11月在伦敦哈维安学会发表》
Br Med J. 1900 Dec 1;2(2083):1566-7. doi: 10.1136/bmj.2.2083.1566.
9
National survey of tuberculosis prevalence in Viet Nam.越南全国结核病患病率调查。
Bull World Health Organ. 2010 Apr;88(4):273-80. doi: 10.2471/BLT.09.067801. Epub 2010 Feb 22.
10
Deaths from respiratory tuberculosis in institutions in the United States, 1945.1945年美国机构内呼吸道结核病死亡情况
Public Health Rep (1896). 1947 Sep 5;62(36):1296-1315.